NASDAQ:RLMD

Relmada Therapeutics, Inc.

Company facts

Most recent report
8-K, filed Sep 8, 2026
Incorporated
Nevada
Filings on record
606 filings
On EDGAR
CIK 1553643
Fiscal year ends
December
Filer status
Non-accelerated filer, Smaller reporting company

Financials 8 of 52

News 8 of 150

Prospectuses and Registrations 8 of 47

Proxies 8 of 33

Ownership 8 of 266

Other 8 of 58

Everything here comes from Relmada Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.